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A B S T R A C T
Numerous animal studies have consistently shown that early life exposure to LP (low-protein)
diet programmes risk factors for CVD (cardiovascular disease) such as dyslipidaemia, high BP
(blood pressure) and cardiac dysfunction in the offspring. However, studies on the effect of
maternal under-nutrition on offspring development of atherosclerosis are scarce. Applying our LP
model to the ApoE− / − atherosclerosis-prone mouse model, we investigated the development of
atherosclerotic lesions in the aortic root of 6-month-old offspring. In addition, markers of plaque
progression including SMA (smooth muscle actin) and Mac3 (macrophage marker 3) were studied.
Pregnant dams were fed on a control (20% protein) or on an isocaloric LP diet (8% protein)
throughout pregnancy and lactation. After weaning, male offspring were maintained on 20%
normal laboratory chow. At 6 months of age, LP offspring showed a significantly greater plaque
area (P< 0.05) with increased cholesterol clefts and significantly higher indices of DNA damage
compared with controls (P< 0.05). The expression of HMG-CoA reductase (3-hydroxy-3-methyl-
glutaryl-CoA reductase) (P< 0.05) and LDL (low-density lipoprotein) receptor in the liver of LP
offspring were increased. Furthermore, LP offspring had higher LDL-cholesterol levels (P< 0.05)
and a trend towards elevated insulin. There were no differences in other lipid measurements and
fasting glucose between groups. These observations suggest that early exposure to an LP diet
accelerates the development and increases the progression of atherosclerotic lesions in young
adult offspring. Future studies are needed to elucidate the specific mechanisms linking in utero
exposure to a diet low in protein to the development of atherosclerosis.
INTRODUCTION
The DOHaD (Developmental Origins of Health and
Disease) hypothesis proposes that insults acting during
critical periods of growth and development may have a
long-term effect on susceptibility to chronic diseases later
in life [1]. The organism responds to these early insults
by adapting its phenotype to the environment resulting in
alteration of growth, body composition, tissue and organ
structure, gene expression and/or metabolism. Although
these adaptations are vital for immediate benefit, many of
them are permanent and may be disadvantageous when
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there is a mismatch between the actual environment and
the one predicted in utero [1–3].
Although many insults can arise during development,
maternal under-nutrition is one of the best characterized.
For instance, populations exposed to short periods of
famine have been studied to investigate the importance
of maternal nutrition in mediating the relationship
between nutrition in utero and future adult disease [4,5].
A cohort exposed in utero to famine in early gestation
during the Dutch Hunger Winter of 1944–1945 were
found to be more likely to develop premature coronary
heart disease and presented with a more atherogenic lipid
profile than individuals born the year before the famine
[4]. In addition, a recent study of individuals exposed to
the 1967–1970 Biafran famine showed elevated systolic
and diastolic BP (blood pressure) following adjustment
for BMI (body mass index) [6]. These observations
provide epidemiological evidence that early exposure
to under-nutrition during critical periods of growth
and development has long-term detrimental effects on
cardiovascular health.
Epidemiological studies largely rely on gathering
data retrospectively from birth cohorts, providing
limited information on potential molecular mechanisms.
Therefore experimental animal models have been
developed to understand the underlying mechanisms
through which nutrition during pre- and early post-natal
development could affect susceptibility to adult chronic
diseases [7]. The maternal LP (low-protein) rodent
model devised by Snoeck et al. [8] is one of the
most extensively documented. This model has provided
evidence of a direct link between sub-optimal maternal
nutrition and alterations in offspring cardiac function
and structure. For example, young adult rats exposed
to the maternal LP diet during pregnancy and lactation
show cardiac abnormalities, including an elevated basal
HR (heart rate) and an attenuated β-adrenergic response,
suggestive of premature heart failure [9].
There are very few studies in animal models addressing
the programming of atherosclerosis [10–13]. This is likely
to reflect the inherent difficulties of such studies in
rodents, as they are highly resistant to atherosclerosis
[14]. In contrast with humans, mice naturally have
high levels of HDL (high-density lipoprotein) and low
levels of LDL (low-density lipoprotein). Genetically
modified mice with disorders in lipid metabolism,
such as inactivation of the gene encoding the ApoE
(apolipoprotein E) are therefore essential when studying
atherosclerosis in rodents [15]. In ApoE− /− mice,
cholesterol is largely distributed between VLDL
(very-LDL) and IDL (intermediate-density lipoprotein)
fractions; however, LDL also forms a major contribution
[16].
ApoE− /− mice are considered to be an effective model
for studying the pathogenesis of atherosclerosis because
they are hypercholesterolaemic and develop spontaneous
arterial lesions [17]. We applied our LP model of early
sub-optimal nutrition to the ApoE− /− mouse model
of atherosclerosis, with the aim of investigating the
development and progression of atherosclerotic lesions
following maternal and early postnatal under-nutrition.
Atherosclerotic plaque deposition in the aortic root
of 6-month-old offspring was quantified and markers
indicative of plaque progression were studied.
MATERIALS AND METHODS
Animal protocol
All experimental procedures were conducted according
to the British Home Office Animals Act, 1986. Pregnant
ApoE− /− mice of the C57BL6/J background were
housed one per cage, kept in standard environmental
conditions (12 h light/12 h dark cycle, room temperature
of 23 ◦C) and fed on either a control diet containing 20%
protein or an isocaloric 8% LP diet during pregnancy
and lactation; the maternal LP diet was supplemented
with carbohydrate to match the calorie content of the
control diet. Composition of bothmaternal diets has been
published previously [9]. Fresh diet was provided every
2–3 days and distilled water administered ad libitum.
Maternal body weight and food intake were recorded
daily during pregnancy and lactation. Birth occurred on
approximately day 20 of pregnancy. This was considered
PND0 (postnatal day 0). There was no effect of maternal
diet on litter size. At 21 days of age male pups were
weaned, housed in litters (three or four pups per cage) and
fed standard laboratory chow containing 20% protein
(LAD1; SDS). Animals were maintained on this diet until
analysis at 6 months of age.
Heart perfusion–fixation
Male ApoE− /− offspring (6-months old) were fasted
overnight, weighed and killed by carbon dioxide
overdose. Subsequently, blood was collected followed by
in situ perfusion–fixation of the heart using a washout
phase of 20 ml of PBS, followed by fixation with 20 ml
of 10% NBF (neutral buffered formalin) via the left
ventricle. After perfusion–fixation, the heart was post-
fixed in 10% NBF for 24 h and stored in PBS at 4 ◦C for
further analysis.
Histology
Samples stored in PBS were prepared by removal of fat
and connective tissue. Subsequently, tissuewas processed,
paraffin-embedded and cut into 5 μm serial sections. To
preserve integrity of the aortic valve region, the entire
heart of each animal was sectioned from its apex to
the source of the coronary arteries, close to the point
of greatest occlusion by plaque. This landmark was
used as a basis for which sections were subsequently
collected. The aortic root has three valve leaflets and
deposition of plaque was measured in each. Sections
C© The Authors Journal compilation C© 2012 Biochemical Society
© 2012 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
Poor maternal nutrition programmes a pro-atherosclerotic phenotype in ApoE− /− mice 253
were de-paraffinated and processed for staining or
immunohistochemistry as described below. A single
section of aortic root was used for each of the separate
staining protocols per animal.
H&E (haematoxylin and eosin) for lesion
size analysis
Sections were stained with H&E (Sigma HHS-32 and
E8017) to allow the quantification of atherosclerosis
and cholesterol cleft content within the aortic root.
Atherosclerotic lesion area was measured for each of the
three leaflets of the aortic root. Total plaque area was
calculated by summing the three leaflet values for each
animal and averaging these values according to group
exposure. Imaging software CellD (Olympus) was used
to circumscribe the borders of each plaque to generate
plaque area (μm2) as described previously [18,19].
Immunohistochemistry
Specific primary antibodies were used for the following:
α-SMA (α-smooth muscle actin) (DAKO M0851,
1:500 dilution), Mac3 (macrophage marker 3) (M3/84;
Pharmingen, 1:200 dilution), p-ATM [phospho-ATM
(ataxia telangiectasia mutated)] (Cell Signaling Techno-
logy 4526, 1:200 dilution) and p-H2AX [phospho-H2AX
(histone H2AX)] (Cell Signaling Technology 2577, 1:200
dilution). SMA and Mac3 content was calculated by
expressing total positive stain as a percentage of total
plaque area. p-ATM and p-H2AX were assessed by
counting the total number of positive staining cells
per animal, then subsequently expressing this positive
staining per 100000 μm2 plaque area. Images were
captured using aBX51microscope (Olympus), air-cooled
CCD (charge-coupled-device) camera (CoolSnap) and
imaging software (CellD and Adobe Photoshop).
Blood collection and analysis
Blood was obtained from each animal at the time of death
by cardiac puncture, and tail blood was used for analysis
of glucose concentration (OneTouch Ultra; LifeScan).
Blood was allowed to clot and centrifuged for 3 min at
8000 g and the supernatant serum kept at − 80 ◦C for
subsequent analysis of lipids (mouse phenotyping facility,
Department of Clinical Biochemistry) and fasting insulin
(Ultrasensitive mouse insulin EIA kit; Mercodia). We did
not directly measure VLDL; however, the concentration
of LDLwas derived using the Friedwald equation, which
includes the VLDL fraction.
Western blotting
Liver-derived protein lysate was resolved by SDS/PAGE
(10% polyacrylamide gels). Proteins were transferred to
PVDF membranes (Immobilon-P; Millipore) at 110 mV.
Membraneswere blocked [3% low fatmilk (Marvel), PBS
and 0.1% Tween] at 4 ◦C overnight. Primary antibodies
to the HMG-CoA reductase (3-hydroxy-3-methyl-
glutaryl-CoA reductase) (Abgent AP6577c), p-HMG-
CoA reductase [phospho-HMG-CoA reductase (Ser872)]
(Millipore 09-356) and LDL receptor (Biosciences Lifes-
ciences ABE1252) were incubated with the membrane
for 1 h. Membranes were washed and incubated with
HRP (horseradish peroxidase)-conjugated secondary
antibody (anti-rabbit) and binding detected using Super
Signal West Pico Chemiluminescent substrate (Thermo
Scientific 34078) and Amersham Hyperfilm ECL (GE
Healthcare).
Statistical analysis
Results represent the number (n) of different litters
as only one animal from each litter was used in
the analysis. Where data showed a normal Gaussian
distribution, results are presented as means+− S.E.M. and
analysed by an independent Student’s t test. Data not
normally distributed were analysed non-parametrically
and are presented as medians (interquartile ranges)
or log-transformed and are presented as means [95%
CI (confidence interval)]. Differences were considered
significant at P< 0.05.
RESULTS
Body weights
Offspring exposed to an LP diet throughout pregnancy
and lactation showed no difference in body weight at
day 3 when compared with controls. Body weight
was significantly reduced in LP offspring at weaning
(LP, 6.31+− 0.24 g, n= 12; controls, 7.44+− 0.37 g, n= 7;
P< 0.05). There was no difference in bodyweight at 6
months of age between groups (LP, 29.3+− 0.7 g, n= 12;
controls; 30.8+− 0.8 g, n= 6).
Atherosclerosis
Atherosclerotic plaque development was analysed in
the aortic root of both offspring groups at 6 months
of age. LP offspring had a greater total plaque area
per animal compared with controls (P< 0.05; Figure 1).
Furthermore, LP offspring had greater total cholesterol
cleft containing area compared with control offspring
(P< 0.05; Figure 2).
Immunohistochemistry
Atherosclerotic plaque phenotype was assessed by
immunohistochemistry to quantify VSMC (vascular
smooth muscle cell) content, inflammation and DNA
damage. LP offspring showed a significant reduction in
VSMCs indicated by attenuated SMA positive staining
(P< 0.05; Table 1). DNA damage marker p-H2AX
was significantly increased in the atherosclerotic plaque
of LP offspring, compared with controls (P< 0.05),
whereas inflammatory marker Mac3 and p-ATM were
not different between the two groups (Table 1).
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Figure 1 Aortic root sections from 6-month-old offspring
stained for H&E and analysed for plaque area
(A) Total plaque area per animal: controls (n = 6) and LP offspring (n = 12).
(B) Representative control and LP H&E stains used for the calculation of plaque
area, ∗P < 0.05.
Figure 2 Aortic root sections analysed from 6-month-old
offspring stained for total cholesterol cleft content
(A) Total plaque area (μm2) containing cholesterol clefts per animal: controls
(n = 6) and LP offspring (n = 12). (B) Representative images of cholesterol cleft
content in one chosen animal for both control and LP offspring, ∗P < 0.05.
Serum analysis
Total and LDL-cholesterol levels in LP offspring were
higher than control offspring at 6 months of age (P< 0.05
Table 1 Characteristics of aortic root plaques of male
offspring at 6 months of age
Values are expressed as medians (25th–75th percentile). LP, n = 11; Control,
n = 6. ∗P < 0.05.
Characteristic Control LP
SMA staining/plaque area (%) 5.7 (2.7–10.2) 2.8 (1.1–6.2)∗
Mac3 staining/plaque area (%) 8.8 (2.3–15.8) 9.2 (4.1–17.0)
p-ATM cells/100 000 μm2 plaque area 82 (50–133) 105 (61–157)
p-H2AX cells/100 000 μm2 plaque area 14 (10–47) 36 (28–83)∗
Table 2 Serum measurements of male offspring at
6 months of age
Values are expressed as means+− S.E.M. or medians (25th–75th percentile). LP,
n = 6; Control, n = 6. ∗P < 0.05 and ∗∗P < 0.01.
Measurement Control LP
Total cholesterol (mmol/l) 6.73+− 1.01 9.77+− 0.78∗
LDL-cholesterol (mmol/l) 4.62+− 0.70 8.65+− 0.70∗∗
HDL-cholesterol (mmol/l) 0.63+− 0.12 0.44+− 0.11
Triacylglycerol (mmol/l) 1.30+− 0.14 1.52+− 0.19
Non-esterified fatty acids (μmol/l) 728 (705–1217) 1011 (706–1573)
Glucose (mmol/l) 5.4+− 0.3 5.9+− 0.4
Insulin (μg/l) 0.26 (0.15–0.35) 0.49 (0.30–0.90)
and P< 0.01 respectively; Table 2). LP offspring showed
a trend to elevated insulin, whereas no significant
differences were observed in other lipid measurement or
fasting glucose (Table 2).
Western blotting
Protein expression of the rate-limiting enzyme in the
synthesis of cholesterol HMG-CoA reductase was
significantly increased in the livers of LP offspring
compared with controls, expressed as a percentage
of control mean (P< 0.05; Figure 3). LDL receptor,
responsible for clearance of LDL from the circulation,
was elevated in LP offspring (LP, 177+− 38, n= 4; and
controls, 100+− 33, n= 7).
DISCUSSION
The main finding of the present study was that exposure
to an LP diet early in life accelerates the development
and progression of atherosclerotic lesions in young
adult offspring. Both human and animal studies have
consistently shown that early life exposure to maternal
under-nutrition programmes dyslipidaemia [4,13,20],
high BP [21,22] and cardiac dysfunction in the offspring
[9,23]. However, these are all risk factors for CVD
(cardiovascular disease) rather than disease outcome.
For instance, it has been shown that the interaction of
prenatal under-nutritionwith a postnatal atherogenic diet
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Figure 3 Western blot analysis of liver from 6-month-old
offspring probing for hepatic HMG-CoA reductase
Controls (n = 4) and LPs (n = 7), ∗P < 0.05.
increases atherosclerosis in female ApoE∗3 Leiden mice,
but has no effect on male offspring [13]. In the present
study, we did not expose pregnant dams or their offspring
to a high-fat diet in order not to interfere with the
spontaneous development of the atherosclerotic lesions.
To our knowledge, this is the first study to report the sole
effect of impaired maternal nutrition on atherosclerotic
plaque development and accelerated progression in the
aortic root of ApoE− /− male offspring at 6 months of
age.
The atherosclerotic lesion initially forms in the
arterial intima and is characterized by intimal thickening
arising from cellular and lipid accumulation [24].
In the intima, lipoproteins undergo spontaneous or
cell-mediated modifications resulting in fatty streaks.
These fatty streaks are not obstructive or clinically
significant. However, they can progress to form more
complex lesions. The progression to a fibrous cap or
fibroatheroma, the characteristic lesion of more advanced
atherosclerosis, consists of the development of a cap of
smooth muscle cells, collagen and a lipid-rich necrotic
core [25]. The fibrous cap is a common site of plaque
rupture induced by macrophage and T-cell infiltration
combined with apoptosis and shear stress [26]. A plaque
containing a thick fibrous cap is considered stable [27,28],
whereas unstable or vulnerable lesions prone to rupture
are characterized by thinning of the fibrous cap and
loss of VSMC content. Loss of VSMCs within the cap
has been associated with increased lesion growth and
progression [18,19]. In response to sub-optimal maternal
nutrition, LP offspring had a significantly greater
plaque area compared with controls. Furthermore, the
atherosclerotic lesions in these offspring showed reduced
SMA positive staining, indicative of VSMC loss and
fibrous cap thinning. Increased DNA damage has been
observed in human atherosclerotic plaques, therefore we
chose to investigate two markers of DNA damage, p-
H2AX and p-ATM [29,30]. Increased levels of DNA
damage marker p-H2AX staining was observed in the
shoulder region of the plaques. These results indicate that
the atherosclerotic plaques of LP offspring were not only
larger but showed enhanced lesion progression compared
with controls.
The role of LDL-cholesterol in the pathogenesis
of atherosclerosis is well documented [25]. LP
offspring showed elevated total and LDL-cholesterol
concentrations compared with controls. Owing to the
known role of serum cholesterol in the pathogenesis
of atherosclerosis it could be hypothesized that the
enhanced atherosclerosis observed in LP offspring is
a consequence of their increased serum cholesterol
concentrations. Furthermore, expression of hepatic
HMG-CoA reductase was also significantly increased in
the LP offspring. This enzyme catalyses the conversion of
HMG-CoA tomevalonate, an early and rate-limiting step
in cholesterol biosynthesis [31]. InhibitionofHMG-CoA
reductase using statins reduces serum LDL-cholesterol
and reverses atherosclerotic plaque development [32,33],
thereby reducing the risk of cardiovascular events
and subsequent mortality [34,35]. The mechanisms
underlying the programmed increase in HMG-CoA
reductase are unknown; however, it is possible that
epigenetic mechanisms are involved. These observations
also suggest that the increased LDL-cholesterol levels
in LP offspring is the result of programmed changes
affecting de novo cholesterol biosynthesis.
The observation that LDL receptors were increased in
the presence of raised cholesterol levels appears at first
paradoxical. The role of the LDL receptor is normally to
remove excess cholesterol from the blood [36]. However,
it can be argued that the increased LDL receptor
levels reflect an unsuccessful compensatory response to
normalize serum cholesterol levels. Themechanistic basis
of such a compensatory mechanism is unclear.
In conclusion, we have shown maternal under-
nutrition through protein deficiency accelerates the
development of atherosclerosis in young adult offspring.
In particular, we demonstrated that atherosclerotic
lesion development and progression are susceptible
to alterations in early nutrition. Further studies are
needed to elucidate the specific molecular mechanism
and pathway by which exposure to under-nutrition early
in life leads to the development of more progressive
atherosclerotic lesions later in life.
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